Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 2/20 | 0.39 |
| ▸ | AHR | P35869 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22960257 | 0.80 | CHRM2 (0.53) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL2675092 | 0.76 | ALDH1A1 (0.43) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL22247986 | 0.76 | AHR (0.46) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL6002998 | 0.76 | ALDH1A1 (0.48) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL31450995 | 0.76 | AHR (0.45) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL11389406 | 0.76 | KDM4E (0.43) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL22273765 | 0.76 | KDM4E (0.47) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL4449379 | 0.76 | KDM4E (0.46) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL31318453 | 0.76 | CYP2C19 (0.46) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT | |
| SCHEMBL15442574 | 0.76 | KDM4E (0.43) | KDM4EALDH1A1HPGDSMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852195-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852189-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852194-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852210-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118852211-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4132939-B1 | POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-01-31 | — | — | EP | disclosed |
| CN-114685454-B | Organic compounds, mixtures, compositions and organic electronic devices | 广州华睿光电材料有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20230389408-A1 | METAL COMPLEX AND USE THEREOF | SICHUAN AG-RAY NEW MATERIALS CO., LTD (CN) | 2023-11-30 | — | — | US | disclosed |
| US-20230389408-A1 | METAL COMPLEX AND USE THEREOF | SICHUAN AG-RAY NEW MATERIALS CO., LTD (CN) | 2023-11-30 | — | — | US | disclosed |
| CN-116217605-B | Polycyclic compound and light-emitting device thereof | 维思普新材料（苏州）有限公司 | 2023-11-10 | — | — | CN | disclosed |
| WO-2000007997-A1 | IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS | ABBOTT LABORATORIES (US) | 2000-02-17 | — | — | WO | disclosed |
| EP-0393838-B1 | Dopamine receptor ligands and imaging agents | UNIV PENNSYLVANIA (US) | 1997-06-25 | — | — | EP | disclosed |
| EP-0773927-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996004241-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |
| US-5426189-A | Dopamine receptor ligands and imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-06-20 | — | — | US | disclosed |
| US-5334728-A | Dopamine receptor ligands and imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1994-08-02 | — | — | US | disclosed |
| US-5186921-A | 3-methoxy-n(1-ethyl-2-pyrrolidinyl)methyl)naphthyl-2-carboxy amide compounds for imaging human brains; good retention stability | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1993-02-16 | — | — | US | disclosed |
| US-5122361-A | 2-Pyrrolidinylmethylcarboxamido-2,3-dihydrobenzofuran type compounds | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1992-06-16 | — | — | US | disclosed |
| EP-0444889-A1 | Novel synthesis of carbapenem intermediates | MERCK & CO. INC. (US) | 1991-09-04 | — | — | EP | disclosed |
| EP-0393838-A1 | Dopamine receptor ligands and imaging agents | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389408-A1 | METAL COMPLEX AND USE THEREOF | CYBA, AP1M1, AP3M1 | KDM4E 4142/4885ALDH1A1 779/4885HPGD 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.